Stonegate Investment Group LLC Decreases Stock Holdings in GE HealthCare Technologies Inc. $GEHC

Stonegate Investment Group LLC lessened its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 10.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 875,796 shares of the company’s stock after selling 105,146 shares during the quarter. GE HealthCare Technologies makes up about 1.5% of Stonegate Investment Group LLC’s holdings, making the stock its 24th largest position. Stonegate Investment Group LLC owned 0.19% of GE HealthCare Technologies worth $65,772,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Allianz SE increased its holdings in shares of GE HealthCare Technologies by 165.2% in the 2nd quarter. Allianz SE now owns 350 shares of the company’s stock valued at $26,000 after acquiring an additional 218 shares during the last quarter. E Fund Management Hong Kong Co. Ltd. boosted its holdings in GE HealthCare Technologies by 130.7% in the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock valued at $26,000 after purchasing an additional 196 shares in the last quarter. Godsey & Gibb Inc. purchased a new position in GE HealthCare Technologies in the third quarter valued at approximately $26,000. Gladwyn Financial Advisors Inc. acquired a new stake in GE HealthCare Technologies during the second quarter worth approximately $34,000. Finally, Piscataqua Savings Bank raised its holdings in GE HealthCare Technologies by 173.4% during the third quarter. Piscataqua Savings Bank now owns 473 shares of the company’s stock worth $36,000 after purchasing an additional 300 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research firms recently commented on GEHC. Evercore ISI reaffirmed an “outperform” rating and issued a $95.00 target price on shares of GE HealthCare Technologies in a research report on Monday, January 5th. Weiss Ratings reissued a “hold (c+)” rating on shares of GE HealthCare Technologies in a report on Monday, December 29th. Wells Fargo & Company decreased their price target on GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating for the company in a report on Thursday, October 30th. Jefferies Financial Group raised their price objective on shares of GE HealthCare Technologies from $95.00 to $105.00 and gave the company a “buy” rating in a research report on Thursday, December 11th. Finally, Barclays initiated coverage on GE HealthCare Technologies in a report on Monday, October 13th. They issued an “equal weight” rating and a $86.00 target price for the company. Seven investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, GE HealthCare Technologies currently has a consensus rating of “Hold” and a consensus target price of $89.83.

GE HealthCare Technologies Trading Up 0.6%

Shares of GEHC stock opened at $80.27 on Tuesday. The stock has a market cap of $36.56 billion, a P/E ratio of 16.58, a P/E/G ratio of 2.41 and a beta of 1.08. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $94.80. The business has a fifty day simple moving average of $82.17 and a 200-day simple moving average of $77.26.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, beating analysts’ consensus estimates of $1.05 by $0.02. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The firm had revenue of $5.14 billion for the quarter, compared to analysts’ expectations of $5.07 billion. During the same period in the prior year, the company earned $1.14 EPS. The firm’s revenue was up 5.8% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Friday, January 9th will be paid a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, January 9th. GE HealthCare Technologies’s dividend payout ratio (DPR) is 2.89%.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.